Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction
Top Cited Papers
Open Access
- 14 June 2000
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (22) , 2941-2947
- https://doi.org/10.1001/jama.283.22.2941
Abstract
In the treatment of acute myocardial infarction (MI), rapid time to treatment with thrombolytic therapy and rapid achievement of reperfusion of the infarct-related artery with thrombolytic therapy (the "open artery theory") is beneficial.1-5 Angiographic studies have supported the link between higher 90-minute (but not 180-minute) infarct-related artery patency and improved survival,4,6 suggesting that small differences in time to achieving reperfusion make clinically important differences in mortality. Primary (or "direct") angioplasty has been found to be a useful means of achieving reperfusion in acute ST-elevation MI compared with thrombolytic therapy in randomized clinical trials.7-10 However, no mortality benefit of primary angioplasty over thrombolysis was observed in several registries in which the delays in performing primary angioplasty were longer.11-14 In these studies, the time between hospital arrival and performance of the primary angioplasty, the so-called door-to-balloon time,5 was on average between 2 and 3 hours,11-14 much longer than in the initial clinical trials.7,8 We hypothesized that, in accord with experimental15 and clinical studies,1-5 the more rapidly reperfusion is achieved with primary angioplasty the better the survival, and conversely, that delays in achieving reperfusion would result in higher mortality. Because prior studies of primary angioplasty have involved only 2007 to 130016-18 patients, it has not been possible to assess reliably the effect of time delays on mortality. We prospectively tested this hypothesis in the Second National Registry of Myocardial Infarction (NRMI-2), which included more than 27,000 patients treated with primary angioplasty. (A list of NRMI-2 investigators and sites is available from the data coordinating center: Ovation Research Group, Highland Park, Ill.)Keywords
This publication has 28 references indexed in Scilit:
- Relationship Between Delay in Performing Direct Coronary Angioplasty and Early Clinical Outcome in Patients With Acute Myocardial InfarctionCirculation, 1999
- Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarctionJournal of the American College of Cardiology, 1998
- Dangers of Delay of Initiation of Either Thrombolysis or Primary Angioplasty in Acute Myocardial Infarction With Increasing Use of Primary AngioplastyThe American Journal of Cardiology, 1998
- Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative reviewJAMA, 1997
- Effect of Continuous Quality Improvement Analysis on the Delivery of Primary Percutaneous Transluminal Coronary Angioplasty for Acute Myocardial InfarctionThe American Journal of Cardiology, 1997
- A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial InfarctionNew England Journal of Medicine, 1996
- Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarctionThe American Journal of Cardiology, 1994
- A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977